Millipore's Q3 Sales Up 12 Percent on Strong Bioscience Growth | GenomeWeb
NEW YORK (GenomeWeb News) - Millipore yesterday said third-quarter revenues increased 12 percent as R&D spending swelled 8 percent and profit shot up nearly 150 percent.
 
Total receipts for the three months ended Sept. 29 increased to $371.2 million from $330.1 million year over year.
 
Sales in the company's Bioprocess segment rose 8 percent to $210.5 million, while Bioscience revenue rose 19 percent to $160.7 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.